Idi, a leading player in the French private equity market, has announced that it is in exclusive negotiations to sell its minority interest in Winncare.
Winncare is a European leader in the design and manufacture of medical devices aimed at improving the quality of life for people with loss of autonomy, as well as their caregivers and healthcare providers. Positioned in two strategic markets—home care and specialized facilities (nursing homes)—the group offers a comprehensive range of products and services, including therapeutic mattresses and cushions for pressure ulcer prevention, connected fall detection solutions, medical beds, and patient transfer systems.
Winncare has undergone a dual-phase scale-up, with revenue growing from 45 million euros in 2014 to 75 million euros in 2021, and reaching nearly 150 million euros by 2025. This growth was driven by a robust M&A strategy, which saw the completion of four strategic acquisitions since 2021: Pharmaouest and Scemed in France, and Herida Medical and Five Mobility in the United Kingdom.
This new transaction aims to support the group's strong growth trajectory by mobilizing additional financial and strategic resources. The renewed investor pool, led by Siparex ETI (majority shareholder since 2021) and including Kartesia, Crédit Agricole, and BNP Paribas, will support management in accelerating a strategy focused on international expansion, a continued active external growth policy, and sustained organic growth within a favorable demographic context, while accelerating its innovation program.
IDI, a leading player in French private equity, is a listed investment company, controlled and majority-owned by its teams, specializing for over 50 years in supporting SMEs and mid-sized companies. IDI offers entrepreneurs time, resources, and a long-term, experienced investment team to accelerate their growth. The commitment and longevity of IDI's teams, along with the quality of its investments, have enabled its shareholders to benefit from an annualized internal rate of return (IRR), with dividends reinvested, of 15.44% since its IPO in 1991.
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
